Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab and Dexamethasone in CRVO
NCT04601701Unknown
- Sponsor
- He Eye Hospital
- Start
- Oct 2020
- Primary completion
- Mar 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of dexamethasone in central retinal vein occlusion (CRVO) and macular edema, sponsored by He Eye Hospital. Primary endpoint: Mean change in monocular Best Corrected Visual Acuity at 6 months. Status: unknown.
02
Drugs
dexamethasone
03
Conditions
central retinal vein occlusion (CRVO)macular edema
Beyond the preview
Go deeper on NCT04601701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04601701.